Showing 1 - 8 results of 8 for search 'Suzanne L. Wolden', query time: 0.04s
Refine Results
-
1
Phantosmia Among Pediatric, Adolescent, and Young Adult Patients Receiving Proton Beam Therapy by Shoshana J. Rosenzweig, BA, Stanislav Lazarev, MD, Shaakir Hasan, DO, Jana Fox, MD, J. Isabelle Choi, MD, Charles B. Simone, II, MD, Suzanne L. Wolden, MD, FACR
Published 2022-03-01
Article -
2
Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review by Matthew Gallitto, BA, Stanislav Lazarev, MD, Isaac Wasserman, MPH, James M. Stafford, PhD, Suzanne L. Wolden, MD, Stephanie A. Terezakis, MD, Ranjit S. Bindra, MD, PhD, Richard L. Bakst, MD
Published 2019-07-01
Article -
3
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey by Enrica Seravalli, Petra S. Kroon, John M. Buatti, Matthew D. Hall, Henry C. Mandeville, Karen J. Marcus, Cem Onal, Enis Ozyar, Arnold C. Paulino, Frank Paulsen, Daniel Saunders, Derek S. Tsang, Suzanne L. Wolden, Geert O. Janssens
Published 2021-07-01
Article -
4
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Onco... by Emily Hibbitts, Yueh‐Yun Chi, Douglas S. Hawkins, Frederic G. Barr, Julie A. Bradley, Roshni Dasgupta, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Sheri L. Spunt, Stephen X. Skapek, Suzanne L. Wolden, Carola A. S. Arndt
Published 2019-10-01
Article -
5
Orbital Exenteration and Brachytherapy for the Treatment of Pediatric, Fusion-positive, Recurrent Rhabdomyosarcoma by Joseph Lopez, MD, MBA, Nancy Qin, BA, Robbie Woods, MD, Marjorie Golden, MFA, CDT, Harrison Spatz, DMD, MS, Jatin Shah, MD, Leonard H. Wexler, MD, Joseph Randazzo, DDS, Suzanne L. Wolden, MD, David H. Abramson, MD
Published 2022-10-01
Article -
6
Metabolic response as assessed by 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabd... by Douglas J. Harrison, Yueh‐Yun Chi, Jing Tian, Pooja Hingorani, Leo Mascarenhas, Geoffrey B. McCowage, Brenda J. Weigel, Rajkumar Venkatramani, Suzanne L. Wolden, Torunn I. Yock, David A. Rodeberg, Andrea A. Hayes‐Jordan, Lisa A. Teot, Sheri L. Spunt, William H. Meyer, Douglas S. Hawkins, Barry L. Shulkin, Marguerite T. Parisi
Published 2021-02-01
Article -
7
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies by Kim Kramer, Neeta Pandit-Taskar, Brian H. Kushner, Pat Zanzonico, John L. Humm, Ursula Tomlinson, Maria Donzelli, Suzanne L. Wolden, Sophia Haque, Ira Dunkel, Mark M. Souweidane, Jeffrey P. Greenfield, Satish Tickoo, Jason S. Lewis, Serge K. Lyashchenko, Jorge A. Carrasquillo, Bae Chu, Christopher Horan, Steven M. Larson, Nai-Kong V. Cheung, Shakeel Modak
Published 2022-11-01
Article -
8
An Update From the Pediatric Proton Consortium Registry by Clayton B. Hess, Daniel J. Indelicato, Arnold C. Paulino, William F. Hartsell, Christine E. Hill-Kayser, Stephanie M. Perkins, Anita Mahajan, Nadia N. Laack, Ralph P. Ermoian, Andrew L. Chang, Suzanne L. Wolden, Victor S. Mangona, Young Kwok, John C. Breneman, John P. Perentesis, Sara L. Gallotto, Elizabeth A. Weyman, Benjamin V. M. Bajaj, Miranda P. Lawell, Beow Y. Yeap, Torunn I. Yock
Published 2018-05-01
Article